LXEO

LXEO Other Income/Expenses (Net)

$7.85MTTM · USD

Period ending:

LXEO FY Other Income/Expenses (Net)USD
LXEO FY Other Income/Expenses (Net)2020-12-31: -$565.00K2021-12-31: $15.00K2022-12-31: $1.23M2023-12-31: $2.12M2024-12-31: $7.43M2025-12-31: $9.30M$9.30M-$565.00K
2020-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LXEO other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 6 observations from Dec 31, 2020 to Dec 31, 2025.

Lexeo Therapeutics Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
9,296,000
7,433,000
2,119,000
1,232,000
15,000
-565,000

Compare other income/expenses (net)

All LXEO financial metrics · LXEO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.